RITTER PHARMACEUTICALS INC - COM NEW (RTTR)

CUSIP: 767836307

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM NEW
Total 13F shares
791,476
Share change
+64,264
Total reported value
$475,000
Price per share
$0.60
Number of holders
9
Value change
-$19,466
Number of buys
2
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 767836307?
CUSIP 767836307 identifies RTTR - RITTER PHARMACEUTICALS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of RITTER PHARMACEUTICALS INC - COM NEW (RTTR) as of Q4 2018

As of 31 Dec 2018, RITTER PHARMACEUTICALS INC - COM NEW (RTTR) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 791,476 shares. The largest 9 holders included SABBY MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, Vanguard Group Inc, ARMISTICE CAPITAL, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., CenterStar Asset Management, LLC, UBS Group AG, and WELLS FARGO & COMPANY/MN. This page lists 9 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.